ModuleTitle@CompanyName@Symbol@Address@Phone@Industry@Sector@Region@CompanyDescription@KeyExecutives@Number_of_employees@Subsidiaries
Company Description@BioMarin Pharmaceutical Inc.@BMRN@105 DIGITAL DRIVE, NOVATO, California, 94949, United States of America@4155066700@Major Pharmaceuticals@Health Care@North America@"BioMarin Pharmaceutical Inc. (BioMarin, we, us or our) is a global biotechnology
company that develops and commercializes innovative therapies for people with
serious and life-threatening rare diseases and medical conditions. We select
product candidates for diseases and conditions that represent a significant
unmet medical need, have well-understood biology and provide an opportunity to
be first-to-market or offer a significant benefit over existing products.
Our portfolio consists of several commercial products and multiple clinical and
preclinical product candidates for the treatment of various diseases. We
continue to invest in our clinical and preclinical product pipeline by
committing significant resources to research and development programs and
business development opportunities within our areas of scientific, manufacturing
and technical expertise.&nbsp;&nbsp;... <a href=""http://secfilings.nasdaq.com/edgar_conv_html%2f2020%2f02%2f27%2f0001048477-20-000009.html#FIS_BUSINESS"" target=""_blank"">More</a> ...&nbsp;&nbsp;
"@[('Brian R. Mueller', 'Chief Financial & Accounting Officer'), ('C. Greg Guyer', 'Chief Technical Officer'), ('Eduardo E. Von Pervieux', 'Chief Information Officer'), ('Geoffrey M. Nichol', 'Chief Medical Officer & Senior Vice President'), ('Henry J. Fuchs', 'President-Worldwide Research & Development'), ('Jean-Jacques BienaimT', 'Chairman & Chief Executive Officer'), ('Lon Cardon', 'Chief Scientific Strategy Officer'), ('Steve Maricich', 'Medical Director-Clinical Sciences')]@['2,581']@['NO INFO']
